Grading dermatologic adverse events of cancer treatments: the Common Terminology Criteria for Adverse Events Version 4.0.

Published

Journal Article

Dermatologic adverse events to cancer therapies have become more prevalent and may to lead to dose modifications or discontinuation of life-saving or prolonging treatments. This has resulted in a new collaboration between oncologists and dermatologists, which requires accurate cataloging and grading of side effects. The Common Terminology Criteria for Adverse Events Version 4.0 is a descriptive terminology and grading system that can be used for uniform reporting of adverse events. A proper understanding of this standardized classification system is essential for dermatologists to properly communicate with all physicians caring for patients with cancer.

Full Text

Duke Authors

Cited Authors

  • Chen, AP; Setser, A; Anadkat, MJ; Cotliar, J; Olsen, EA; Garden, BC; Lacouture, ME

Published Date

  • November 2012

Published In

Volume / Issue

  • 67 / 5

Start / End Page

  • 1025 - 1039

PubMed ID

  • 22502948

Pubmed Central ID

  • 22502948

Electronic International Standard Serial Number (EISSN)

  • 1097-6787

Digital Object Identifier (DOI)

  • 10.1016/j.jaad.2012.02.010

Language

  • eng

Conference Location

  • United States